5.07
-0.0662(-1.29%)
Currency In USD
| Previous Close | 5.14 |
| Open | 5.21 |
| Day High | 5.25 |
| Day Low | 5.07 |
| 52-Week High | 5.82 |
| 52-Week Low | 3.34 |
| Volume | 5,048 |
| Average Volume | 19,075 |
| Market Cap | 45.64M |
| PE | -19.51 |
| EPS | -0.26 |
| Moving Average 50 Days | 5.17 |
| Moving Average 200 Days | 4.45 |
| Change | -0.07 |
If you invested $1000 in ImmuCell Corporation (ICCC) 10 years ago, it would be worth $859.97 as of May 09, 2025 at a share price of $5.074. Whereas If you bought $1000 worth of ImmuCell Corporation (ICCC) shares 5 years ago, it would be worth $1,219.66 as of May 09, 2025 at a share price of $5.074.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
ImmuCell Announces Preliminary, Unaudited Sales Results for Q1 of 2025
GlobeNewswire Inc.
Apr 08, 2025 8:05 PM GMT
PORTLAND, Maine, April 08, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve
ImmuCell Hires Chief Financial Officer
GlobeNewswire Inc.
Apr 07, 2025 1:00 PM GMT
PORTLAND, Maine, April 07, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve
ImmuCell Announces Initiation of Investigational Product Use of Re-Tain®
GlobeNewswire Inc.
Apr 02, 2025 8:05 PM GMT
PORTLAND, Maine, April 02, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve